World

First Copies of Gilead Virus Drug to Start Selling in Bangladesh

Beximco to sell remdesivir at $71 a vial for private clinics
Gilead’s drug cleared by U.S. regulator for emergency use

Earliest Vaccine Release Could Be Early Next Year, Dr. Jonathan Quick Says

Provide news feedback or report an error

Confidential tip?

Send a tip to our reporters

Site feedback:

Take our Survey

By Arun Devnath

May 21, 2020 at 5:30 AM UTC

This article is for subscribers only.

Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.

Bangladesh’s Beximco Pharmaceuticals Ltd. said it has become the world’s first company to start selling the generic version of Gilead Sciences Inc.’s antiviral drug on mounting urgency to treat the infection caused by the deadly coronavirus across the developing world.